Clinical TrialsSearch results
Number of results: 2453
Not yet recruiting
- [M23-703] A Study to Assess Adverse Events and Change in Disease Activity from Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants with Active Ulcerative Colitis
- Ulcerative Colitis
- Otani Tetsuya
- 2024-05-07
Recruiting
- Prevention of artificial urinary sphincter infection
- Male patients with severe urinary incontinence planned for artificial urinary sphincter implantation
- Waseda Yuma
- 2024-05-01
Not yet recruiting
- A study to investigate long-term safety and tolerability of tolebrutinib in participants with multiple sclerosis.
- Relapsing / Secondary progressive / Primary progressive multiple sclerosis
- Tanaka Tomoyuki
- 2024-04-27
Recruiting
- A Proof-of-Concept study to assess the efficacy, safety and tolerability of itepekimab (anti-IL-33 mAb) in participants with non-cystic fibrosis bronchiectasis
- Bronchiectasis
- Tanaka Tomoyuki
- 2024-04-26
Recruiting
- Clinical trial on the usefulness of surgical guidance and support from a remote location using super vision system technology with 8K images for laparoscopic surgery through ultra-high speed communication such as 5G
- colon cancer
- Yukihide Kanemitsu
- 2024-04-26
Recruiting
- EN-MARK
- gastric cancer
- Yamaguchi Kensei
- 2024-04-26
Recruiting
- Efanesoctocog Alfa Multicenter Prospective Observational Study in patients with factor VIII deficiency in Japan
- Patients with blood coagulation factor VIII deficiency
- Kidani Yoko
- 2024-04-25
Recruiting
- Exploring the Sensory Input Pathways with Brain-Spinal Cord fMRI
- Healthy subjects
- Abe Mitsunari
- 2024-04-25
Not yet recruiting
- A multicenter, Single-arm trial to evaluate the efficacy and safety of trifluridine therapy for patients with conjunctivitis caused by mpox virus.
- Conjunctivitis caused by Mpox virus
- Morioka Shinichiro
- 2024-04-25
Not yet recruiting
- Platform Clinical Study to Evaluate the Safety and Efficacy of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis
- Patients with interstitial lung disease (ILD) secondary to systemic sclerosis (SSc) (SSc-ILD)
- Kay Richard
- 2024-04-25